BC

Bank Clariden Leu

Europe, Zurich, Switzerland, Zürich

Description

Bank Clariden Leu is a swiss private bank.

Investor Profile

Bank Clariden Leu has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series C (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Consulting
  • Data Center
  • Information Technology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bank Clariden Leu frequently co-invest with?

Lombard Odier
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 1
BankInvest
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Lurie Investment Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
NAI Elliott
North America, Oregon, United States, Portland
Co-Investments: 1
AI
North America, New York, United States, Greenport
Co-Investments: 1
Deutsche Bank
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
Perry Capital
North America, New York, United States, New York
Co-Investments: 1
Albert Fried & Company
North America, New York, United States, New York
Co-Investments: 1
PV
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Bank Clariden Leu?

Altus Pharmaceuticals

Independence, Ohio, United States

Altus is an information technology consulting firm with global impact.

ConsultingData CenterInformation TechnologyPharmaceutical
Series CMay 26, 2004
Amount Raised: $51,000,000
Palatin Technologies

Cranbury, New Jersey, United States

Palatin Technologies is a biopharmaceutical company developing targeted receptor specific peptide therapeutics to treat diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJan 30, 2004
Amount Raised: $22,700,000